GLP-1 Desk · provider dispatches
Every GLP-1 provider, dispatched on the facts.
The Desk scores telehealth weight-loss providers on six measurable dimensions — price transparency, state access, molecule range, onboarding speed, support responsiveness, and licensing trust — and issues a Desk Score for each. Reader-supported: assume any provider we list may compensate us.
- Providers scored
- 508
- Scoring factors
- 6
- Last dispatch update
- Aug 11
Why read the Desk before you sign up anywhere
Standing rankings
Shopping one molecule? Start here.
Most readers want one drug's shortlist, not the full roster. On the Desk-Score rankings, partners are placed first, per our disclosure — the score itself never moves for it. The price rankings are not ordered that way: they run strictly cheapest-first, funded or not.
Desk Score
Highest Desk Score here — placement is funded, this number is not
CoreAge Rx
The Desk's top dispatch: flat all-in pricing, both molecules, all 50 states — no teaser-rate traps.
Read the full dispatch →The Desk
Scored on: price transparency · state access · molecule range · onboarding speed · support responsiveness · licensing & trust. Assume any provider we list may compensate us — see our disclosure. Partners are placed first below; the Desk Score itself never moves for it.
- A94/100
Desk Score
The Desk's top dispatch: flat all-in pricing, both molecules, all 50 states — no teaser-rate traps.
- Strut Health
From $99/mo sublingual, $149/mo injectable semaFrom $199/mo either route tirz
B+88/100Desk Score
The same molecule as a lozenge or an injection at the same price — the only place in this ranking where the needle is genuinely optional.
FDAWarning letter issued to Strut Health, LLC dba Strut in February 2026. See the FDA warning-letter database.
- Sesame Care
From $149/mo (brand Wegovy pill) semaBrand Zepbound (price varies) tirz
B+87/100Desk Score
An established national telehealth marketplace with the widest real brand-name GLP-1 access in the ranking — Wegovy (pen and pill), Zepbound, Ozempic and Mounjaro — plus provider-by-provider price transparency.
- Pallas Health
$199/mo average (compounded injectable; $597 billed every 12 weeks after $139 for the first 4 weeks; no month-to-month tier is sold) sema$299/mo average (compounded injectable; $897 billed every 12 weeks after $179 for the first 4 weeks; no month-to-month tier is sold) tirz
B+87/100Desk Score
Pallas Health names all six of the pharmacies that dispense for it and two prescribing clinicians whose NPIs verify in the federal registry — then sells every GLP-1 on a single twelve-week prepay, so the advertised “/mo average” is one $597 or $897 charge divided by three.
- HealthRX
$189/mo (compounded) sema$349/mo (GLP+GIP) tirz
B86/100Desk Score
A LegitScript-certified telehealth desk with a rare oral GLP tablet route alongside injectables and physician-reviewed intake.
- RxSpan MD
From $194/mo sema$329/mo tirz
B86/100Desk Score
A physician-founded desk with one of the widest menus in the ranking — compounded and brand-name GLP-1 across injectable and oral routes, microdosing, plus longevity, hair, and sexual-health lines — with transparent, all-inclusive pricing across all 50 states.
- Sprout Health
$149/mo sema$199/mo tirz
B86/100Desk Score
A LegitScript-certified desk that pairs low-cost compounded semaglutide and tirzepatide with a real brand-name Wegovy and Zepbound path — and a near-frictionless, often visit-free start.
FDAWarning letter issued to Sprout Health Partners LLC dba Sprout Health in September 2025. See the FDA warning-letter database.
- MadeMed
$239/mo quarterly (from $199/mo on 6 months) sema$399/mo quarterly (from $369/mo on 6 months) tirz
B86/100Desk Score
Publishes its price at every single dose, so what month six costs is knowable on day one.
- Enhance MD
$212/mo sema$280/mo tirz
B85/100Desk Score
The clearest tiered compounded pricing in the ranking — separate lines for sema, tirzepatide, a microdose tier, and a sema+tirz combo — with lab testing built in.
- Telos Rx
$145/mo (compounded) sema$99/mo (annual) tirz
B85/100Desk Score
The broadest published catalog in the ranking — compounded GLP-1s plus oral and microdosed tirzepatide, PT-141, intranasal NAD+, and recovery peptides — all compounded and not FDA-approved.
That is the top 10 of the 508 providers the Desk scores, in ranking order. The rest are scored on the same six dimensions — every dispatch is indexed here, or compare two head-to-head on the comparison desk.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on the provider's own site. Not medical advice.
Evidence
Great sourced content, not just rankings
Every claim on the Desk is tied to primary research or official labeling — each piece shows its source count up front.
- 5 sources cited
Semaglutide vs Tirzepatide: Which Molecule Fits You
The two GLP-1 molecules head to head — trial weight-loss data, the single-vs-dual mechanism, and how to decide which one to ask your provider for.
- 4 sources cited
Injections vs Oral or Sublingual GLP-1: What to Know
Weekly injections carry the trial-grade weight-loss evidence; oral and sublingual GLP-1 trade some data for convenience. How to weigh the route.
- 4 sources cited
Ozempic vs Wegovy: Same Drug, Two Different FDA Approvals
Ozempic and Wegovy are both semaglutide. What differs is the FDA-approved indication, the maximum dose, and a cardiovascular-risk claim only one carries.